Literature DB >> 15210960

The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging.

Luigi Zecca1, Antonella Stroppolo, Alberto Gatti, Davide Tampellini, Marco Toscani, Mario Gallorini, Giuseppe Giaveri, Paolo Arosio, Paolo Santambrogio, Ruggero G Fariello, Erdem Karatekin, Mark H Kleinman, Nicholas Turro, Oleh Hornykiewicz, Fabio A Zucca.   

Abstract

In this study, a comparative analysis of metal-related neuronal vulnerability was performed in two brainstem nuclei, the locus coeruleus (LC) and substantia nigra (SN), known targets of the etiological noxae in Parkinson's disease and related disorders. LC and SN pars compacta neurons both degenerate in Parkinson's disease and other Parkinsonisms; however, LC neurons are comparatively less affected and with a variable degree of involvement. In this study, iron, copper, and their major molecular forms like ferritins, ceruloplasmin, neuromelanin (NM), manganese-superoxide dismutase (SOD), and copper/zinc-SOD were measured in LC and SN of normal subjects at different ages. Iron content in LC was much lower than that in SN, and the ratio heavy-chain ferritin/iron in LC was higher than in the SN. The NM concentration was similar in LC and SN, but the iron content in NM of LC was much lower than SN. In both regions, heavy- and light-chain ferritins were present only in glia and were not detectable in neurons. These data suggest that in LC neurons, the iron mobilization and toxicity is lower than that in SN and is efficiently buffered by NM. The bigger damage occurring in SN could be related to the higher content of iron. Ferritins accomplish the same function of buffering iron in glial cells. Ceruloplasmin levels were similar in LC and SN, but copper was higher in LC. However, the copper content in NM of LC was higher than that of SN, indicating a higher copper mobilization in LC neurons. Manganese-SOD and copper/zinc-SOD had similar age trend in LC and SN. These results may explain at least one of the reasons underlying lower vulnerability of LC compared to SN in Parkinsonian syndromes.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15210960      PMCID: PMC470762          DOI: 10.1073/pnas.0403495101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  48 in total

1.  A new major projection from locus coeruleus: the main source of noradrenergic nerve terminals in the ventral and dorsal columns of the spinal cord.

Authors:  L G Nygren; L Olson
Journal:  Brain Res       Date:  1977-08-19       Impact factor: 3.252

2.  Regional topography within noradrenergic locus coeruleus as revealed by retrograde transport of horseradish peroxidase.

Authors:  S T Mason; H C Fibiger
Journal:  J Comp Neurol       Date:  1979-10-15       Impact factor: 3.215

3.  Noradrenergic mechanisms in age-related cognitive decline.

Authors:  A F Arnsten; P S Goldman-Rakic
Journal:  J Neural Transm Suppl       Date:  1987

4.  Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.

Authors:  R J D'Amato; Z P Lipman; S H Snyder
Journal:  Science       Date:  1986-02-28       Impact factor: 47.728

5.  Chronic manganese intoxication.

Authors:  D G Cook; S Fahn; K A Brait
Journal:  Arch Neurol       Date:  1974-01

6.  Effects of putative neurotransmitters on neuronal activity in monkey auditory cortex.

Authors:  S L Foote; R Freedman; A P Oliver
Journal:  Brain Res       Date:  1975-03-21       Impact factor: 3.252

7.  Studies on neuromelanin. II. Melanin in the brainstems of infants and children.

Authors:  G M Fenichel; M Bazelon
Journal:  Neurology       Date:  1968-08       Impact factor: 9.910

8.  Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.

Authors:  J R Connor; P J Boyer; S L Menzies; B Dellinger; R P Allen; W G Ondo; C J Earley
Journal:  Neurology       Date:  2003-08-12       Impact factor: 9.910

9.  Increased iron (III) and total iron content in post mortem substantia nigra of parkinsonian brain.

Authors:  E Sofic; P Riederer; H Heinsen; H Beckmann; G P Reynolds; G Hebenstreit; M B Youdim
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

10.  Iron and other metals in neuromelanin, substantia nigra, and putamen of human brain.

Authors:  L Zecca; R Pietra; C Goj; C Mecacci; D Radice; E Sabbioni
Journal:  J Neurochem       Date:  1994-03       Impact factor: 5.372

View more
  164 in total

1.  A calorie-restricted diet decreases brain iron accumulation and preserves motor performance in old rhesus monkeys.

Authors:  Erik K Kastman; Auriel A Willette; Christopher L Coe; Barbara B Bendlin; Kris J Kosmatka; Donald G McLaren; Guofan Xu; Elisa Canu; Aaron S Field; Andrew L Alexander; Mary Lou Voytko; T Mark Beasley; Ricki J Colman; Richard H Weindruch; Sterling C Johnson
Journal:  J Neurosci       Date:  2010-06-09       Impact factor: 6.167

2.  Oxidatively generated DNA damage after Cu(II) catalysis of dopamine and related catecholamine neurotransmitters and neurotoxins: Role of reactive oxygen species.

Authors:  Wendy A Spencer; Jeyaprakash Jeyabalan; Sunita Kichambre; Ramesh C Gupta
Journal:  Free Radic Biol Med       Date:  2010-11-12       Impact factor: 7.376

3.  Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.

Authors:  F A Zucca; C Bellei; S Giannelli; M R Terreni; M Gallorini; E Rizzio; G Pezzoli; A Albertini; L Zecca
Journal:  J Neural Transm (Vienna)       Date:  2006-04-28       Impact factor: 3.575

4.  Mechanism of DNA damage and apoptosis induced by tetrahydropapaveroline, a metabolite of dopamine.

Authors:  Hatasu Kobayashi; Shinji Oikawa; Shosuke Kawanishi
Journal:  Neurochem Res       Date:  2006-05-16       Impact factor: 3.996

5.  The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface.

Authors:  William D Bush; Jacob Garguilo; Fabio A Zucca; Alberto Albertini; Luigi Zecca; Glenn S Edwards; Robert J Nemanich; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

6.  Saturation Binding of Nicotine to Synthetic Neuromelanin Demonstrated by Fluorescence Spectroscopy.

Authors:  Robert L Haining; Travis M Jones; Aubrey Hernandez
Journal:  Neurochem Res       Date:  2016-09-23       Impact factor: 3.996

Review 7.  Oxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's disease.

Authors:  Georgia S Gaki; Athanasios G Papavassiliou
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

8.  Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia.

Authors:  William Lin; Natasha L Wadlington; Linan Chen; Xiaoxi Zhuang; James R Brorson; Un Jung Kang
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

9.  Neuromelanin activates microglia and induces degeneration of dopaminergic neurons: implications for progression of Parkinson's disease.

Authors:  Wei Zhang; Kester Phillips; Albert R Wielgus; Jie Liu; Alberto Albertini; Fabio A Zucca; Rudolph Faust; Steven Y Qian; David S Miller; Colin F Chignell; Belinda Wilson; Vernice Jackson-Lewis; Serge Przedborski; Danielle Joset; John Loike; Jau-Shyong Hong; David Sulzer; Luigi Zecca
Journal:  Neurotox Res       Date:  2009-12-03       Impact factor: 3.911

10.  Neuromelanin organelles are specialized autolysosomes that accumulate undegraded proteins and lipids in aging human brain and are likely involved in Parkinson's disease.

Authors:  Fabio A Zucca; Renzo Vanna; Francesca A Cupaioli; Chiara Bellei; Antonella De Palma; Dario Di Silvestre; Pierluigi Mauri; Sara Grassi; Alessandro Prinetti; Luigi Casella; David Sulzer; Luigi Zecca
Journal:  NPJ Parkinsons Dis       Date:  2018-06-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.